Adalimumab is effective in achieving clinical and endoscopic long-term deep remission: A case report

We report the case of a 61-year-old woman with aggressive and complicated steroid-dependant Crohn's disease in whom clinical and endoscopic long-term deep remission was achieved for up to 3 years, without any need for steroids, hospitalization or surgery.
Source: Digestive and Liver Disease Supplements - Category: Gastroenterology Source Type: research